You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 38 Issue 2

July 2013

Volume 38, Issue 2

Pages 77–211

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
  2. META-ANALYSIS

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
  3. RANDOMISED CLINICAL TRIAL

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
  4. HEPATITIS C

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
      Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral (pages 118–123)

      K. Rutter, H. Hofer, S. Beinhardt, M. Dulic, M. Gschwantler, A. Maieron, H. Laferl, A. F. Stättermayer, T.-M. Scherzer, R. Strassl, H. Holzmann, P. Steindl-Munda and P. Ferenci

      Version of Record online: 26 MAY 2013 | DOI: 10.1111/apt.12350

    2. You have free access to this content
  5. NON-ALCOHOLIC STEATOHEPATITIS

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
      Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis (pages 134–143)

      J. H. Hoofnagle, M. L. Van Natta, D. E. Kleiner, J. M. Clark, K. V. Kowdley, R. Loomba, B. A. Neuschwander-Tetri, A. J. Sanyal, J. Tonascia and the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN)

      Version of Record online: 29 MAY 2013 | DOI: 10.1111/apt.12352

  6. UPPER GI BLEEDING

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
      Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy (pages 144–150)

      S. Sheibani, J. J. Kim, B. Chen, S. Park, B. Saberi, K. Keyashian, J. Buxbaum and L. Laine

      Version of Record online: 28 MAY 2013 | DOI: 10.1111/apt.12347

  7. ULCERATIVE COLITIS

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
      Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis (pages 151–161)

      E. Varela, C. Manichanh, M. Gallart, A. Torrejón, N. Borruel, F. Casellas, F. Guarner and M. Antolin

      Version of Record online: 3 JUN 2013 | DOI: 10.1111/apt.12365

  8. COELIAC DISEASE

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
      Young adults with coeliac disease may be at increased risk of early atherosclerosis (pages 162–169)

      S. De Marchi, G. Chiarioni, M. Prior and E. Arosio

      Version of Record online: 3 JUN 2013 | DOI: 10.1111/apt.12360

  9. FUNCTIONAL DYSPEPSIA

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
      Functional dyspepsia: the economic impact to patients (pages 170–177)

      B. E. Lacy, K. T. Weiser, A. T. Kennedy, M. D. Crowell and N. J. Talley

      Version of Record online: 3 JUN 2013 | DOI: 10.1111/apt.12355

  10. NSAIDS VS COXIBS?

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
      Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? (pages 178–189)

      G. M. C. Masclee, V. E. Valkhoff, E. M. van Soest, R. Schade, G. Mazzaglia, M. Molokhia, G. Trifirò, J. L. Goldstein, S. Hernández-Díaz, E. J. Kuipers and M. C. J. M. Sturkenboom

      Version of Record online: 28 MAY 2013 | DOI: 10.1111/apt.12348

  11. GERD

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
  12. INVITED COMMENTARIES

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
  13. LETTERS TO THE EDITORS

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content
    2. You have free access to this content
      Letter: mucosal healing in ulcerative colitis – higher relevance than in Crohn's disease? Authors' reply (page 208)

      D. Laharie, J. Filippi, X. Roblin, S. Nancey and L. Peyrin-Biroulet

      Version of Record online: 17 JUN 2013 | DOI: 10.1111/apt.12361

    3. You have free access to this content
      Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitis (pages 208–209)

      J. Umeno, M. Esaki, Y. Nuki, H. Kim, T. Kitazono and T. Matsumoto

      Version of Record online: 17 JUN 2013 | DOI: 10.1111/apt.12356

    4. You have free access to this content
  14. CORRIGENDUM

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSIS
    4. RANDOMISED CLINICAL TRIAL
    5. HEPATITIS C
    6. NON-ALCOHOLIC STEATOHEPATITIS
    7. UPPER GI BLEEDING
    8. ULCERATIVE COLITIS
    9. COELIAC DISEASE
    10. FUNCTIONAL DYSPEPSIA
    11. NSAIDS VS COXIBS?
    12. GERD
    13. INVITED COMMENTARIES
    14. LETTERS TO THE EDITORS
    15. CORRIGENDUM
    1. You have free access to this content

SEARCH

SEARCH BY CITATION